Skip to main content
Log in

Pulmonary vascular disease in a failed Fontan patient with Down’s syndrome

  • Case Report
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

It is well known that Down’s syndrome is a strong risk factor for mortality after Fontan operations. We performed two lung biopsies in a Down’s syndrome patient who underwent staged Fontan operations. The pathological findings revealed severe pulmonary arterial hypertrophy and a quantitative real-time polymerase chain reaction revealed the overexpression of endothelin and a decline in the eNOS level at the Fontan operation. Although the preoperative hemodynamic studies revealed that all of the criteria for Fontan had been fulfilled, the patient died of acute cardiac insufficiency, 35 days after the Fontan operation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gupta-Malhotra M, Larson VE, Rosengart RM, Guo H, Moller JH. Mortality after total cavopulmonary connection in children with the Down syndrome. Am J Cardiol. 2010;105:865–8.

    Article  PubMed  Google Scholar 

  2. Furukawa T, Park IS, Yoshikawa T, Nishimura T, Takahashi Y, Ando M, et al. Outcome of univentricular repair in patients with Down syndrome. J Thorac cardiovasc Surg. 2013;146:1349–52.

    Article  PubMed  Google Scholar 

  3. Wada N, Takahashi Y, Ando M, Park IS, Sasaki T. Single ventricle repair in children with Down’s syndrome. Gen Thorac Caidiovasc Surg. 2008;56:104–8.

    Article  Google Scholar 

  4. Yamaki S, Tezuka F. Quantitative analysis of pulmonary vascular disease in complete transposition of the great arteries. Circulation. 1976;54:805–9.

    Article  CAS  PubMed  Google Scholar 

  5. Maeda K, Yamaki S, Kado H, Asou T, Murakami A, Takamoto S. Reevaluation of histomorphometric analysis of lung tissue in decision making for better patient selection for Fontan-type operations. Ann Thorac Surg. 2004;78:1371–81.

    Article  PubMed  Google Scholar 

  6. Ishida H, Kogaki S, Ichimori H, Narita J, Nawa N, et al. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol. 2012;159:34–9.

    Article  PubMed  Google Scholar 

  7. D’Alto M, Romeo E, Argiento P, D’Andrea A, Sarubbi B, Correra A, et al. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down’s syndrome. Int J Cardiol. 2013;164:323–6.

    Article  PubMed  Google Scholar 

  8. Saji T. Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int. 2014;56:297–303.

    Article  CAS  PubMed  Google Scholar 

  9. Henaine R, Vergnat M, Bacha EA, Baudet B, Lambert V, Belli E, et al. Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation. J Thorac Cardiovasc Surg. 2013;146:522–9.

    Article  CAS  PubMed  Google Scholar 

  10. Henaine R, Vergnat M, Mercier O, Serraf A, Montpreville VD, Ninet J, et al. Hemodynamics and arteriovenous malformations in cavopulmonary anastomosis: the case for residual antegrade pulsatile flow. J Thorac Cardiovasc Surg. 2013;146:1359–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaya Aoki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aoki, M., Hirono, K., Higuma, T. et al. Pulmonary vascular disease in a failed Fontan patient with Down’s syndrome. Gen Thorac Cardiovasc Surg 66, 299–302 (2018). https://doi.org/10.1007/s11748-017-0809-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-017-0809-6

Keywords

Navigation